"Immunity, Innate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS.
Descriptor ID |
D007113
|
MeSH Number(s) |
G12.450.564
|
Concept/Terms |
Immunity, Innate- Immunity, Innate
- Immunity, Non-Specific
- Immunity, Non Specific
- Non-Specific Immunity
- Innate Immune Response
- Immune Response, Innate
- Immune Responses, Innate
- Innate Immune Responses
- Immunity, Native
- Native Immunity
- Innate Immunity
- Immunity, Natural
- Natural Immunity
|
Below are MeSH descriptors whose meaning is more general than "Immunity, Innate".
Below are MeSH descriptors whose meaning is more specific than "Immunity, Innate".
This graph shows the total number of publications written about "Immunity, Innate" by people in this website by year, and whether "Immunity, Innate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 1 | 2 | 3 |
1997 | 0 | 1 | 1 |
1998 | 0 | 2 | 2 |
1999 | 1 | 3 | 4 |
2000 | 0 | 5 | 5 |
2001 | 0 | 9 | 9 |
2002 | 0 | 4 | 4 |
2003 | 2 | 8 | 10 |
2004 | 6 | 7 | 13 |
2005 | 5 | 13 | 18 |
2006 | 6 | 12 | 18 |
2007 | 15 | 6 | 21 |
2008 | 16 | 12 | 28 |
2009 | 12 | 11 | 23 |
2010 | 8 | 20 | 28 |
2011 | 21 | 14 | 35 |
2012 | 21 | 19 | 40 |
2013 | 17 | 12 | 29 |
2014 | 21 | 12 | 33 |
2015 | 17 | 9 | 26 |
2016 | 14 | 23 | 37 |
2017 | 12 | 15 | 27 |
2018 | 12 | 12 | 24 |
2019 | 9 | 19 | 28 |
2020 | 13 | 9 | 22 |
2021 | 11 | 5 | 16 |
2022 | 3 | 8 | 11 |
2023 | 1 | 13 | 14 |
2024 | 14 | 6 | 20 |
2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunity, Innate" by people in Profiles.
-
Hirako IC, Ramalho T, Gazzinelli RT. Immune regulation of host energy metabolism and periodicity of malaria parasites. Philos Trans R Soc Lond B Biol Sci. 2025 Jan 23; 380(1918):20230511.
-
Bharadwaj R, Jaiswal S, Silverman N. Cytosolic delivery of innate immune agonists. Trends Immunol. 2024 Dec; 45(12):1001-1014.
-
Stillman JM, Kiniwa T, Schafer DP. Nucleic acid sensing in the central nervous system: Implications for neural circuit development, function, and degeneration. Immunol Rev. 2024 10; 327(1):71-82.
-
Dang EV, Reboldi A. Cholesterol sensing and metabolic adaptation in tissue immunity. Trends Immunol. 2024 Nov; 45(11):861-870.
-
Lee S, Silverman N, Gao FB. Emerging roles of antimicrobial peptides in innate immunity, neuronal function, and neurodegeneration. Trends Neurosci. 2024 Nov; 47(11):949-961.
-
Dong M, Fitzgerald KA. DNA-sensing pathways in health, autoinflammatory and autoimmune diseases. Nat Immunol. 2024 Nov; 25(11):2001-2014.
-
Tse-Kang SY, Wani KA, Peterson ND, Page A, Humphries F, Pukkila-Worley R. Intestinal immunity in C.?elegans is activated by pathogen effector-triggered aggregation of the guard protein TIR-1 on lysosome-related organelles. Immunity. 2024 10 08; 57(10):2280-2295.e6.
-
Tse-Kang SY, Pukkila-Worley R. Lysosome-related organelle integrity suppresses TIR-1 aggregation to restrain toxic propagation of p38 innate immunity. Cell Rep. 2024 09 24; 43(9):114674.
-
Perego M, Yeon M, Agarwal E, Milcarek AT, Bertolini I, Camisaschi C, Ghosh JC, Tang HY, Grandvaux N, Ruscetti M, Kossenkov AV, Preston-Alp S, Tempera I, Auslander N, Altieri DC. Parkin activates innate immunity and promotes antitumor immune responses. J Clin Invest. 2024 Aug 30; 134(22).
-
Chibaya L, DeMarco KD, Lusi CF, Kane GI, Brassil ML, Parikh CN, Murphy KC, Chowdhury SR, Li J, Ma B, Naylor TE, Cerrutti J, Mori H, Diaz-Infante M, Peura J, Pitarresi JR, Zhu LJ, Fitzgerald KA, Atukorale PU, Ruscetti M. Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer. Sci Transl Med. 2024 Aug 28; 16(762):eadj9366.